UPDATE 1-Valeant CEO Papa plans to lower debt by more than $1.5 bln in 2016

NEW YORK, May 23 (Reuters) - Valeant Pharmaceuticals Inc

plans to lower its debt by at least $1.5 billion this

year, Chief Executive Officer Joseph Papa said on Monday during

his first large meeting...

Read more